PMC:7105881 / 58869-59196 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1757","span":{"begin":51,"end":59},"obj":"Species"},{"id":"1758","span":{"begin":65,"end":73},"obj":"Species"},{"id":"1759","span":{"begin":160,"end":165},"obj":"Species"},{"id":"1760","span":{"begin":166,"end":170},"obj":"Species"},{"id":"1761","span":{"begin":211,"end":220},"obj":"Species"},{"id":"1762","span":{"begin":290,"end":305},"obj":"Species"}],"attributes":[{"id":"A1757","pred":"tao:has_database_id","subj":"1757","obj":"Tax:694009"},{"id":"A1758","pred":"tao:has_database_id","subj":"1758","obj":"Tax:1335626"},{"id":"A1759","pred":"tao:has_database_id","subj":"1759","obj":"Tax:9606"},{"id":"A1760","pred":"tao:has_database_id","subj":"1760","obj":"Tax:11118"},{"id":"A1761","pred":"tao:has_database_id","subj":"1761","obj":"Tax:2697049"},{"id":"A1762","pred":"tao:has_database_id","subj":"1762","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T331","span":{"begin":8,"end":15},"obj":"Body_part"}],"attributes":[{"id":"A331","pred":"fma_id","subj":"T331","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T281","span":{"begin":51,"end":59},"obj":"Disease"}],"attributes":[{"id":"A281","pred":"mondo_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T674","span":{"begin":160,"end":165},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25253","span":{"begin":8,"end":15},"obj":"Chemical"}],"attributes":[{"id":"A79894","pred":"chebi_id","subj":"T25253","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"2_test","denotations":[{"id":"32265848-32005086-36511237","span":{"begin":321,"end":325},"obj":"32005086"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T315","span":{"begin":0,"end":327},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T979","span":{"begin":6,"end":15},"obj":"PG_1"},{"id":"T980","span":{"begin":51,"end":59},"obj":"SP_10"},{"id":"T981","span":{"begin":65,"end":73},"obj":"SP_9"},{"id":"T982","span":{"begin":160,"end":165},"obj":"SP_6;NCBITaxon:9606"},{"id":"T983","span":{"begin":211,"end":220},"obj":"SP_7"},{"id":"T984","span":{"begin":294,"end":305},"obj":"NCBITaxon:11118"},{"id":"T78099","span":{"begin":6,"end":15},"obj":"PG_1"},{"id":"T46216","span":{"begin":51,"end":59},"obj":"SP_10"},{"id":"T64127","span":{"begin":65,"end":73},"obj":"SP_9"},{"id":"T79853","span":{"begin":160,"end":165},"obj":"SP_6;NCBITaxon:9606"},{"id":"T74733","span":{"begin":211,"end":220},"obj":"SP_7"},{"id":"T2395","span":{"begin":294,"end":305},"obj":"NCBITaxon:11118"}],"text":"Since S protein and its fragments, such as RBD, of SARS-CoV, and MERS-CoV are prime targets for developing subunit vaccines against these two highly pathogenic human CoVs, it is expected that similar regions of 2019-nCoV can also be used as key targets for developing vaccines against this new coronavirus (Jiang et al., 2020)."}